Microenvironmental adaptation of experimental tumours to chronic vs acute hypoxia

British Journal of Cancer

Volumn 91, Issue 6, 2004, Pages 1181-1189

  Thews, O ^a   Wolloscheck, T ^a   Dillenburg, W ^a   Kraus, S ^a   Kelleher, D K ^a   Konerding, M A ^a   Vaupel, P ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Cell proliferation; Hypoxia; Oxygenation; Perfusion; Vascularity; VEGF

Indexed keywords

DNA; VASCULOTROPIN;

ACUTE HYPOXIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD FLOW; CELL PROLIFERATION; CHRONIC HYPOXIA; CONTROLLED STUDY; EXPERIMENTAL MEDICINE; FUNCTIONAL ASSESSMENT; HYPOXIA; HYPOXIC CELL; IN VIVO STUDY; MALE; METABOLIC REGULATION; MICROENVIRONMENT; NONHUMAN; OXYGEN TENSION; OXYGENATION; PERFUSION; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SARCOMA; TISSUE PERFUSION; TUMOR GROWTH; TUMOR MODEL;

ACUTE DISEASE; ANIMALS; CELL DIVISION; CELL HYPOXIA; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DNA REPLICATION; DNA, NEOPLASM; KINETICS; MALE; NEOPLASMS, EXPERIMENTAL; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 5044239737     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602066     Document Type: Article

References (65)

1. Acs G, Acs P, Beckwith SM, Pitts RL, Clements E, Wong K, Verma A (2001) Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res 61: 3561-3565
2. Acs G, Zhang PJ, McGrath CM, Acs P, McBroom J, Mohyeldin A, Liu S, Lu H, Verma A (2003) Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol 162: 1789-1806
3. Amellem O, Pettersen EO (1991) Cell inactivation and cell cycle inhibition as induced by extreme hypoxia: the possible role of cell cycle arrest as a protection against hypoxia-induced lethal damage. Cell Prolif 24: 127-141
4. Blancher C, Moore JW, Talks KL, Houlbrook S, Harris AL (2000) Relationship of hypoxia-inducible factor (HIF)-1α and HIF-2α expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res 60: 7106-7113
5. Brown JM (1993) SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumors. Br J Cancer 67: 1163-1170
6. Buchler P, Reber HA, Buchler M, Shrinkante S, Buchler MW, Friess H, Semenza GL, Hines OJ (2003) Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer. Pancreas 26: 56-64
7. Bush RS, Jenkin RD, Allt WE, Beale FA, Bean H, Dembo AJ, Pringle JF (1978) Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer (Suppl) 37: 302-306
8. Chaplin DJ, Hill SA (1995) Temporal heterogeneity in microregional erythrocyte flux in experimental solid tumours. Br J Cancer 71: 1210-1213
9. Chaplin DJ, Olive PL, Durand RE (1987) Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res 47: 597-601
10. Coleman CN, Mitchell JB, Camphausen K (2001) Tumor hypoxia: chicken, egg, or piece of the farm? J Clin Oncol 20: 610-615
11. Coleman CN, Urtasun RC, Wasserman TH, Hancock S, Harris JW, Halsey J, Hirst VK (1984) Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508. Int J Radiat Oncol Biol Phys 10: 1749-1753
12. Dachs GU, Tozer GM (2000) Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur J Cancer 36: 1649-1660
13. Damert A, Machein M, Breier G, Fujita MQ, Hanahan D, Risau W, Plate KH (1997) Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res 57; 3860-3864
14. Feldkamp MM, Lau N, Rak J, Kerbel RS, Guha A (1999) Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras. Int J Cancer 81: 118-124
15. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186
16. Folkman J (1995) Clinical applications of research on angiogenesis. N Engl J Med 333: 1757-1763
17. Fujii T, Otsuki T, Moriya T, Sakaguchi H, Kurebayashi J, Yata K, Uno M, Kobayashi T, Kimura T, Jo Y, Kinugawa K, Furukawa Y, Morioka M, Ueki A, Tanaka H (2002) Effect of hypoxia on human seminoma cells. Int J Oncol 20: 955-962
18. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OCA (1953) The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26: 638-648
19. Greco O, Tozer GM, Dachs GU (2002) Oxic and anoxic enhancement of radiation-mediated toxicity by horseradish peroxidase/indole-3-acetic acid gene therapy. Int J Radiat Biol 78: 173-181
20. Harris AL (2002) Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47
21. Harrison DK, Kessler M, Knauf SK (1990) Regulation of capillary blood flow and oxygen supply in skeletal muscle in dogs during hypoxaemia. J Physiol 420: 431-446
22. Henderson BW, Fingar VH (1987) Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res 47: 3110-3114
23. Henk JM, Bishop K, Shepherd SF (2003) Treatment of head and neck cancer with CHART and nimorazole: phase II study. Radiother Oncol 66: 65-70
24. Hirst DG (1989) Tumor blood flow modification therapeutic benefit: is this approach ready for clinical application? Review. In Gray Laboratory 1989 Annual Report, : Michael B, Hance M (eds) pp 14-17, London: Cancer Research Campaign
25. Hirst DG, Hirst VK, Joiner B, Prise V, Shaffi KM (1991) Changes in tumour morphology with alterations of oxygen availability: further evidence for oxygen as a limiting substrate. Br J Cancer 64: 54-58
26. Hirst DG, Wood PJ (1987a) The adaptive response of mouse tumours to anaemia and retransfusion. Int J Radiat Biol Relat Stud Phys Chem Med 51: 597-609
27. Hirst DG, Wood PJ (1987b) The influence of haemoglobin affinity for oxygen on tumour radiosensitivity. Br J Cancer 55: 487-491
28. Höckel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biological, and molecular aspects. J Natl Cancer Inst 93: 266-276
29. Horsman MR (1993) Hypoxia in tumors: its relevance, identification and modification. In Medical Radiology Current Topics in Clinical Radiobiology of Tumors, Beck-Bornholdt H-P (ed) pp 99-112, Berlin, Heidelberg: Springer-Verlag
30. Hubloue I, Biarent D, Abdel KS, Bejjani G, Kerbaul F, Naeije R, Leeman M (2003) Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction. Eur Respir J 21: 19-24
31. Huss WJ, Hanrahan CF, Barrios RJ, Simons JW, Greenberg NM (2001) Angiogenesis and prostate cancer: identification of a molecular progression switch. Cancer Res 61: 2736-2743
32. Kelleher DK, Engel T, Vaupel PW (1995) Changes in microregional perfusion, oxygenation, ATP and lactate distribution in subcutaneous rat tumours upon water-filtered IR-A hyperthermia. Int J Hyperthermia 11: 241-255
33. Kelleher DK, Matthiensen U, Thews O, Vaupel P (1996) Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats. Cancer Res 56: 4728-4734
34. Kimura H, Braun RD, Ong ET, Hsu R, Secomb TW, Papahadjopoulos D, Hong K, Dewhirst MW (1996) Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 56: 5522-5528
35. Konerding MA, Malkusch W, Klapthor B, van Ackern C, Fait E, Hill SA, Parkins C, Chaplin DJ, Presta M, Denekamp J (1999) Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts. Br J Cancer 80: 724-732
36. Konerding MA, Steinberg F, Streffer C (1989a) The vasculature of xenotransplanted human melanomas and sarcomas on nude mice. II. Scanning and transmission electron microscopic studies. Acta Anat (Basel) 136: 27-33
37. Konerding MA, Steinberg F, Streffer C (1989b) The vasculature of xenotransplanted human melanomas and sarcomas on nude mice. I. Vascular corrosion casting studies. Acta Anat (Basel) 136: 21-26
38. 2 and beta-estradiol induce VEGF in MCF-7 and MCF-7-5C cells: relationship to in vivo hypoxia. Breast Cancer Res Treat 67: 51-60
39. Marshall JM, Metcalfe JD (1989) Influences on the cardiovascular response to graded levels of systemic hypoxia of the accompanying hypocapnia in the rat. J Physiol 410: 381-394
40. Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW, Ratcliffe PJ (1997) Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 94: 8104-8109
41. Metzen E, Zhou J, Jelkmann W, Fandrey J, Brune B (2003) Nitric oxide impairs normoxic degradation of HIF-1α by inhibition of prolyl hydroxylases. Mol Biol Cell 14: 3470-3481
42. Pilch H, Schlenger K, Steiner E, Brockerhoff P, Knapstein P, Vaupel P (2001) Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts. Int J Gynecol Cancer 11: 137-142
43. Rak J, Yu JL (2004) Oncogenes and tumor angiogenesis: the question of vascular 'supply' and vascular 'demand'. Semin Cancer Biol 14: 93-104
44. Sato A, Trzebski A, Zhou W (1992) Local cerebral blood flow responses in rats to hypercapnia and hypoxia in the rostral ventrolateral medulla and in the cortex. J Auton Nerv Syst 41: 79-86
45. Secomb TW, Hsu R, Ong ET, Gross JF, Dewhirst MW (1995) Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncol 34: 313-316
46. Semenza GL (2002) HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8(Suppl): S62-S67
47. Semenza GL (2000) Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35: 71-103
48. Sutherland RM, Ausserer WA, Murphy BJ, Laderoute KR (1996) Tumor hypoxia and heterogeneity: challenges and opportunities for the future. Semin Radiat Oncol 6: 59-70
49. Tannock IF, Steel GG (1970) Tumor growth and cell kinetics in chronically hypoxic animals. J Natl Cancer Inst 45: 123-133
50. Teicher BA, Holden SA, al Achi A, Herman TS (1990) Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma. Cancer Res 50: 3339-3344
51. Thews O, Kelleher DK, Hummel M, Vaupel P (1999) Can tumor oxygenation be improved by reducing cellular oxygen consumption? Adv Exp Med Biol 471: 525-532
52. Thews O, Kelleher DK, Lecher B, Vaupel P (1997) Effect of cell line and differentiation on the oxygenation status of experimental sarcomas. Adv Exp Med Biol 428: 123-128
53. Thews O, Kelleher DK, Vaupel P (1996) In vivo oxygen consumption rate of DS sarcoma cells on inhibition of DNA synthesis. Cancer Res 56: 2009-2012
54. Thews O, Kelleher DK, Vaupel P (2001) Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors. Cancer Res 61: 1358-1361
55. Thews O, Koenig R, Kelleher DK, Kutzner J, Vaupel P (1998) Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. Br J Cancer 78: 752-756
56. Trzebski A, Sato Y, Suzuki A, Sato A (1995) Inhibition of nitric oxide synthesis potentiates the responsiveness of carotid chemoreceptors to systemic hypoxia in the rat. Neurosci Lett 190: 29-32
57. Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465
58. i. NMR Biomed 7: 128-136
59. 2 tension measurements. Cancer Res 51: 3316-3322
60. Vaupel P, Thews O, Hoeckel M (2001) Treatment resistance of solid tumors - role of hypoxia and anemia. Med Oncol 18: 243-259
61. G-nitro-L-arginine. Cancer Res 54: 6458-6463
62. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin DJ, Double JA, Embleton J, Newell D, Raymond R, Stables J, Stephens T, Wallace J (1998) United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (2nd edit.). Br J Cancer 77: 1-10
63. Wouters BG, Weppler SA, Koritzinsky M, Landuyt W, Nuyts S, Theys J, Chiu RK, Lambin P (2002) Hypoxia as a target for combined modality treatments. Eur J Cancer 38: 240-257
64. Zhang X, Gaspard JP, Chung DC (2001) Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res 61: 6050-6054
65. Ziemer LS, Koch CJ, Maity A, Magarelli DP, Horan AM, Evans SM (2001) Hypoxia and VEGF mRNA expression in human tumors. Neoplasia 3: 500-508